Articles with public access mandates - Peter SavasLearn more
Not available anywhere: 7
Clinical relevance of host immunity in breast cancer: from TILs to the clinic
P Savas, R Salgado, C Denkert, C Sotiriou, PK Darcy, MJ Smyth, S Loi
Nature reviews Clinical oncology 13 (4), 228-241, 2016
Mandates: National Health and Medical Research Council, Australia, Susan G. Komen
Combined CDK4/6 and PI3Kα inhibition is synergistic and immunogenic in triple-negative breast cancer
ZL Teo, S Versaci, S Dushyanthen, F Caramia, P Savas, CP Mintoff, ...
Cancer research 77 (22), 6340-6352, 2017
Mandates: National Health and Medical Research Council, Australia
Oncogene addiction and immunity: clinical implications of tumour infiltrating lymphocytes in breast cancers overexpressing the HER2/neu oncogene
P Savas, F Caramia, ZL Teo, S Loi
Current opinion in oncology 26 (6), 562-567, 2014
Mandates: National Health and Medical Research Council, Australia
Alpelisib monotherapy for PI3K-altered, pretreated advanced breast cancer: a phase II study
P Savas, LL Lo, SJ Luen, EF Blackley, J Callahan, K Moodie, ...
Cancer Discovery 12 (9), 2058-2073, 2022
Mandates: National Health and Medical Research Council, Australia
Validation and characterisation of prognostically significant PD-L1+ immune cells in HPV+ oropharyngeal squamous cell carcinoma
RJ Young, M Bressel, S Porceddu, J Cernelc, P Savas, H Liu, D Urban, ...
Oral Oncology 101, 104516, 2020
Mandates: National Health and Medical Research Council, Australia
Molecular comparison of interval and screen‐detected breast cancers
D Cheasley, N Li, SM Rowley, K Elder, GB Mann, S Loi, P Savas, ...
The Journal of Pathology 248 (2), 243-252, 2019
Mandates: National Health and Medical Research Council, Australia
Dual antiangiogenesis agents bevacizumab plus trebananib, without chemotherapy, in first-line treatment of metastatic colorectal cancer: results of a phase II study
J Mooi, F Chionh, P Savas, J Da Gama Duarte, G Chong, S Brown, ...
Clinical Cancer Research 27 (8), 2159-2167, 2021
Mandates: National Health and Medical Research Council, Australia
Available somewhere: 41
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
S Turajlic, K Litchfield, H Xu, R Rosenthal, N McGranahan, JL Reading, ...
The lancet oncology 18 (8), 1009-1021, 2017
Mandates: Cancer Research UK, UK Medical Research Council, National Institute for …
Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
P Savas, B Virassamy, C Ye, A Salim, CP Mintoff, F Caramia, R Salgado, ...
Nature medicine 24 (7), 986-993, 2018
Mandates: US National Institutes of Health, National Health and Medical Research …
Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology …
S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ...
Advances in anatomic pathology 24 (6), 311-335, 2017
Mandates: US National Institutes of Health, Government of Spain
Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immunooncology …
S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ...
Advances in anatomic pathology 24 (5), 235-251, 2017
Mandates: US National Institutes of Health
Tumor-infiltrating lymphocytes and associations with pathological complete response and event-free survival in HER2-positive early-stage breast cancer treated with lapatinib …
R Salgado, C Denkert, C Campbell, P Savas, P Nuciforo, C Aura, ...
JAMA oncology 1 (4), 448-455, 2015
Mandates: US National Institutes of Health, National Health and Medical Research …
RAS/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: therapeutic cooperation between MEK and PD-1/PD-L1 immune …
S Loi, S Dushyanthen, PA Beavis, R Salgado, C Denkert, P Savas, ...
Clinical Cancer Research 22 (6), 1499-1509, 2016
Mandates: US National Institutes of Health, Susan G. Komen
Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade
IG House, P Savas, J Lai, AXY Chen, AJ Oliver, ZL Teo, KL Todd, ...
Clinical Cancer Research 26 (2), 487-504, 2020
Mandates: National Health and Medical Research Council, Australia
Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of …
SJ Luen, R Salgado, S Fox, P Savas, J Eng-Wong, E Clark, A Kiermaier, ...
The Lancet Oncology 18 (1), 52-62, 2017
Mandates: US National Institutes of Health
Pervasive chromosomal instability and karyotype order in tumour evolution
TBK Watkins, EL Lim, M Petkovic, S Elizalde, NJ Birkbak, GA Wilson, ...
Nature 587 (7832), 126-132, 2020
Mandates: US Department of Defense, US National Institutes of Health, Helmholtz …
Combined immune checkpoint blockade as a therapeutic strategy for BRCA1-mutated breast cancer
E Nolan, P Savas, AN Policheni, PK Darcy, F Vaillant, CP Mintoff, ...
Science translational medicine 9 (393), eaal4922, 2017
Mandates: US National Institutes of Health, National Health and Medical Research …
Relevance of tumor-infiltrating lymphocytes in breast cancer
S Dushyanthen, PA Beavis, P Savas, ZL Teo, C Zhou, M Mansour, ...
BMC medicine 13, 1-13, 2015
Mandates: National Health and Medical Research Council, Australia
Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning
F Klauschen, KR Müller, A Binder, M Bockmayr, M Hägele, P Seegerer, ...
Seminars in cancer biology 52, 151-157, 2018
Mandates: German Research Foundation, Federal Ministry of Education and Research, Germany
The subclonal architecture of metastatic breast cancer: results from a prospective community-based rapid autopsy program “CASCADE”
P Savas, ZL Teo, C Lefevre, C Flensburg, F Caramia, K Alsop, M Mansour, ...
PLoS medicine 13 (12), e1002204, 2016
Mandates: US National Institutes of Health, National Health and Medical Research …
Publication and funding information is determined automatically by a computer program